These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11238257)

  • 1. Acceleration of restenosis by diabetes: pathogenetic implications.
    Sobel BE
    Circulation; 2001 Mar; 103(9):1185-7. PubMed ID: 11238257
    [No Abstract]   [Full Text] [Related]  

  • 2. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty.
    Van Belle E; Ketelers R; Bauters C; Périé M; Abolmaali K; Richard F; Lablanche JM; McFadden EP; Bertrand ME
    Circulation; 2001 Mar; 103(9):1218-24. PubMed ID: 11238264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.
    Van Belle E; Bauters C; Hubert E; Bodart JC; Abolmaali K; Meurice T; McFadden EP; Lablanche JM; Bertrand ME
    Circulation; 1997 Sep; 96(5):1454-60. PubMed ID: 9315531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization?
    Lincoff AM
    Circulation; 1997 Sep; 96(5):1374-7. PubMed ID: 9315518
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenge of high-risk patients: diabetes and small vessels.
    Kereiakes D
    J Invasive Cardiol; 2004 Sep; 16 Suppl F():3F-7F; discussion 18F-21F. PubMed ID: 23573646
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
    Kip KE; Faxon DP; Detre KM; Yeh W; Kelsey SF; Currier JW
    Circulation; 1996 Oct; 94(8):1818-25. PubMed ID: 8873655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and endothelial function: implications for coronary angioplasty.
    Anderson TJ
    Adv Exp Med Biol; 2001; 498():109-14. PubMed ID: 11900356
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty.
    St Claire DA; King SB
    Coron Artery Dis; 1996 Oct; 7(10):744-52. PubMed ID: 8970765
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress with diabetic patients undergoing percutaneous coronary intervention.
    Cohen M
    Eur Heart J; 2004 Jan; 25(2):99-100. PubMed ID: 14720523
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.
    Mazeika P; Prasad N; Bui S; Seidelin PH
    Am Heart J; 2003 Jun; 145(6):1013-21. PubMed ID: 12796757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioplasty vs bypass surgery in patients with multivessel coronary artery disease.
    Guerra CE; Viswanath DB
    JAMA; 1997 Jul; 278(2):114-5. PubMed ID: 9214521
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous coronary intervention for revascularization of the diabetic patient.
    Butts JN; Morgan KP; Beatt KJ
    Br J Hosp Med (Lond); 2006 May; 67(5):253-8. PubMed ID: 16729636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents.
    Whitlow P
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):2S-6S. PubMed ID: 23573564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interventional cardiologist and the diabetic patient. Have we pushed the envelope too far or not far enough?
    Goldberg S; Savage MP; Fischman DL
    Circulation; 1996 Oct; 94(8):1804-6. PubMed ID: 8873650
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary stenting in diabetics: six months clinical and angiographic outcome.
    Kane GR; Patil CV; Sahoo PK; Bhatnagar D; Mathew R; Sethi RB
    Indian Heart J; 2000; 52(4):416-20. PubMed ID: 11084782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty.
    St Claire DA; King SB
    J Cardiovasc Risk; 1997 Apr; 4(2):112-20. PubMed ID: 9304492
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes mellitus and coronary artery disease.
    Bell DS
    Coron Artery Dis; 1996 Oct; 7(10):715-22. PubMed ID: 8970762
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial.
    Giannini F; Latib A; Jabbour RJ; Costopoulos C; Chieffo A; Carlino M; Montorfano M; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(1):4-9. PubMed ID: 28011243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.